BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 20428826)

  • 21. Aberrant methylation of secreted apoptosis-related protein 2 (SARP2) in pure pancreatic juice in diagnosis of pancreatic neoplasms.
    Watanabe H; Okada G; Ohtsubo K; Yao F; Jiang PH; Mouri H; Wakabayashi T; Sawabu N
    Pancreas; 2006 May; 32(4):382-9. PubMed ID: 16670620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
    Seki K; Suda T; Aoyagi Y; Sugawara S; Natsui M; Motoyama H; Shirai Y; Sekine T; Kawai H; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Asakura H
    Clin Cancer Res; 2001 Jul; 7(7):1976-81. PubMed ID: 11448913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
    Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic analysis of pancreatic ductal adenocarcinoma compared with normal adjacent pancreatic tissue and pancreatic benign cystadenoma.
    Cui Y; Tian M; Zong M; Teng M; Chen Y; Lu J; Jiang J; Liu X; Han J
    Pancreatology; 2009; 9(1-2):89-98. PubMed ID: 19077459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Expression of Cell Division Cycle 42 Promotes Pancreatic Cancer Growth and Predicts Poor Outcome of Pancreatic Cancer Patients.
    Yang D; Zhang Y; Cheng Y; Hong L; Wang C; Wei Z; Cai Q; Yan R
    Dig Dis Sci; 2017 Apr; 62(4):958-967. PubMed ID: 28181096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing of GRP94 expression promotes apoptosis in pancreatic cancer cells.
    Pan Z; Erkan M; Streit S; Friess H; Kleeff J
    Int J Oncol; 2009 Oct; 35(4):823-8. PubMed ID: 19724918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer.
    Nishizawa N; Harada H; Kumamoto Y; Kaizu T; Katoh H; Tajima H; Ushiku H; Yokoi K; Igarashi K; Fujiyama Y; Okuwaki K; Iwai T; Watanabe M; Yamashita K
    Cancer Sci; 2019 Sep; 110(9):2846-2855. PubMed ID: 31325200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galectin-1 expression in activated pancreatic satellite cells promotes fibrosis in chronic pancreatitis/pancreatic cancer via the TGF-β1/Smad pathway.
    Tang D; Wu Q; Zhang J; Zhang H; Yuan Z; Xu J; Chong Y; Huang Y; Xiong Q; Wang S; Tian Y; Lu Y; Ge X; Shen W; Wang D
    Oncol Rep; 2018 Mar; 39(3):1347-1355. PubMed ID: 29328490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.
    Karanjawala ZE; Illei PB; Ashfaq R; Infante JR; Murphy K; Pandey A; Schulick R; Winter J; Sharma R; Maitra A; Goggins M; Hruban RH
    Am J Surg Pathol; 2008 Feb; 32(2):188-96. PubMed ID: 18223320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues.
    Matsubayashi H; Sato N; Fukushima N; Yeo CJ; Walter KM; Brune K; Sahin F; Hruban RH; Goggins M
    Clin Cancer Res; 2003 Apr; 9(4):1446-52. PubMed ID: 12684418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced expression of the membrane skeleton protein beta1-spectrin (SPTBN1) is associated with worsened prognosis in pancreatic cancer.
    Jiang X; Gillen S; Esposito I; Giese NA; Michalski CW; Friess H; Kleeff J
    Histol Histopathol; 2010 Dec; 25(12):1497-506. PubMed ID: 20886430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
    Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
    Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A loss-of-function p.G191R variant in the anionic trypsinogen (PRSS2) gene in Japanese patients with pancreatic disorders.
    Kume K; Masamune A; Takagi Y; Kikuta K; Watanabe T; Satoh K; Satoh A; Hirota M; Hamada S; Shimosegawa T
    Gut; 2009 Jun; 58(6):820-4. PubMed ID: 19052022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Next-Generation Sequencing Revealed TP53 Mutations to Be Malignant Marker for Intraductal Papillary Mucinous Neoplasms That Could Be Detected Using Pancreatic Juice.
    Takano S; Fukasawa M; Kadokura M; Shindo H; Takahashi E; Hirose S; Maekawa S; Mochizuki K; Kawaida H; Itakura J; Katoh R; Fujii H; Sato T; Enomoto N
    Pancreas; 2017; 46(10):1281-1287. PubMed ID: 28930868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer.
    Zhang ML; Lu S; Zhou L; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):533-8. PubMed ID: 18842503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic analysis of pancreatic intraepithelial neoplasia and pancreatic carcinoma in rat models.
    Wang L; Liu HL; Li Y; Yuan P
    World J Gastroenterol; 2011 Mar; 17(11):1434-41. PubMed ID: 21472101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.
    Mirus JE; Zhang Y; Hollingsworth MA; Solan JL; Lampe PD; Hingorani SR
    Mol Cell Proteomics; 2014 Dec; 13(12):3484-96. PubMed ID: 25225358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
    Vychytilova-Faltejskova P; Kiss I; Klusova S; Hlavsa J; Prochazka V; Kala Z; Mazanec J; Hausnerova J; Kren L; Hermanova M; Lenz J; Karasek P; Vyzula R; Slaby O
    Diagn Pathol; 2015 Apr; 10():38. PubMed ID: 25908274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil gelatinase-associated lipocalin, macrophage inhibitory cytokine 1, and carbohydrate antigen 19-9 in pancreatic juice: pathobiologic implications in diagnosing benign and malignant disease of the pancreas.
    Kaur S; Baine MJ; Guha S; Ochi N; Chakraborty S; Mallya K; Thomas C; Crook J; Wallace MB; Woodward TA; Jain M; Singh S; Sasson AR; Skinner V; Raimondo M; Batra SK
    Pancreas; 2013 Apr; 42(3):494-501. PubMed ID: 23146921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.
    Shen J; Person MD; Zhu J; Abbruzzese JL; Li D
    Cancer Res; 2004 Dec; 64(24):9018-26. PubMed ID: 15604267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.